If you or a loved one recently received a prostate cancer diagnosis, it might seem like you’ve entered a world full of unfamiliar terms and decisions. It’s normal to feel overwhelmed or unsure about what to do next or which information to trust.
This article covers 10 important facts about prostate cancer, including how common this type of cancer really is, who may be at higher risk, and how the disease is diagnosed and staged. We’ll also talk about possible symptoms and available treatment options — so you can feel more informed and empowered as you move forward.
After skin cancer, prostate cancer is the most common cancer in men in the United States, according to the American Cancer Society. About 1 in 8 men will get a prostate cancer diagnosis at some point.
Because prostate cancer is so common, researchers have learned a lot about how prostate cancer grows and how to treat it.
Many prostate cancers grow slowly, especially in the early stages. The cancer may stay in the prostate gland for years without causing symptoms or spreading. Because of this, doctors may recommend active surveillance — closely monitoring the cancer with regular checkups and tests, also known as watchful waiting — before starting treatments like surgery or radiation.
Certain factors can increase the risk of developing prostate cancer. Having one or more risk factors doesn’t mean you’ll definitely get the disease, but it may be helpful to talk with your doctor about the key risk factors. These include:
Understanding your individual risk level can help you and your doctor make decisions about when to start screening and how to approach early detection.
In many cases, prostate cancer doesn’t cause symptoms at first. When symptoms do appear, they’re often related to changes in urination, such as:
Cancer that spreads beyond the prostate is called advanced or metastatic prostate cancer. This may lead to new symptoms, including:
Any new or worsening symptoms should always be shared with your doctor promptly.
Routine prostate cancer screening means checking for signs of cancer before symptoms appear. The most common method is the prostate-specific antigen (PSA) test, a simple blood test that measures a protein made by the prostate gland. Screening can help find cancer early, when it may be easier to treat. However, screening also comes with risks — such as false positives, unnecessary tests, or added anxiety.
According to the Centers for Disease Control and Prevention (CDC), people ages 55 to 69 should talk with their healthcare providers about whether to have regular PSA screening. The decision is personal and should be made with your care team, considering your individual risk factors and what matters most to you.
Routine screening generally isn’t recommended for people 70 and older, because the potential risks often outweigh the benefits.
A higher-than-normal PSA level found during routine screening doesn’t automatically mean you have prostate cancer. Other conditions, such as benign prostatic hyperplasia (BPH) — an enlarged prostate — can raise PSA. Levels can also rise due to infection, inflammation, or recent medical procedures.
If your PSA level is high, your provider may repeat testing, perform a digital rectal exam (DRE), or order imaging tests to help find the cause.
Prostate cancer is staged at the time of diagnosis. Staging determines how far cancer has spread in the body. The process usually begins with a PSA blood test and a DRE. If results raise concerns, a prostate biopsy (tissue sample) can confirm the diagnosis and help show how aggressive the cancer looks.
Doctors use several tools to assign a stage. For example, the Gleason score describes how aggressive the cancer cells look under a microscope. Lower Gleason scores mean slower-growing cancer, and higher scores mean faster-growing disease. PSA levels and imaging tests — such as MRI, CT scans, and bone scans — can also be used.
Prostate cancer stages range from 1 to 4:
As with other types of cancer, staging helps guide treatment options and predict prognosis (outlook) for prostate cancer.
Your cancer care plan will be based on your age, cancer stage, symptoms, and overall health. Common treatment options include:
Your oncology (cancer) team will help you weigh the benefits and side effects of each option to help you choose the best approach.
Your individual prognosis with prostate cancer depends on multiple factors. These include the cancer’s stage, your Gleason score, PSA levels, and effectiveness of treatments.
Prostate cancer often grows slowly and is highly treatable. Although it’s a leading cause of cancer-related death, most people diagnosed with prostate cancer don’t die from complications of the disease. With the right care, many people live long after their diagnosis.
The good news is that prostate cancer is often curable when found early. For cancers that are still localized (confined to the prostate) or regional (spread only to nearby areas), the five-year relative survival rate is nearly 100 percent. This means that people diagnosed at these stages are about as likely to be alive five years after diagnosis as those without cancer.
If prostate cancer has spread to distant parts of the body, like bones or other organs, the five-year relative survival rate drops to about 38 percent. Even in advanced stages, treatment can help slow the cancer and manage symptoms, supporting a better quality of life.
On MyProstateCancerTeam, people share their experiences with prostate cancer, get advice, and find support from others who understand.
What prostate cancer treatments have you tried? Let others know in the comments below.
Get updates directly to your inbox.
IF YOU DID A MRI AND DID NOT SEE WERE THE CANCER IS WHAT IS THE NEXT STEP
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.